Hospital-Acquired Infections Diagnostics Market Grew 10% in 2011, Suggests Kalorama Information
20 Sep 2012 • by Natalie Aster
The growing focus on hospital-acquired infections (HAI) as a driver of costs and negative outcomes is increasing demand for diagnostic products that can help hospitals and nursing homes decide which patients need treatment and possible isolation.
According to a recent report “Hospital Acquired Infections: Testing Markets” by healthcare market research publisher Kalorama Information, the need to combat HAIs has led to increased sales of IVD products designed to test for these infections, growing 10% in 2011 to reach $1.2 billion.
As put in the study, the most common hospital-acquired infections, or nosocomial infections, interfering with treatment include MRSA, tuberculosis and urinary tract infections. With 5% of the nearly 40 million hospital visits a year resulting in a HAI, nearly 100,000 people die each year from nosocomial infections, a fifth of these from MRSA alone. In the ICU, where infection is most harmful due to the compromised status of patients, community-acquired pneumonia is a growing problem.
“Nosocomial infections are a fact of life in healthcare right now – as one infection may decline, a new infection appears or there is an increase in the incidence of another,” says Bruce Carlson, publisher of Kalorama Information. “Speed is essential in identifying these infections, and there are a host of tests out there, targeting specific infections and offering fast results.”
The simplest test would consist of a nostril swab to detect MRSA and assist in admissions screening to reduce the spread of the disease. Specific to tuberculosis, identifying the M. tuberculosis organism is necessary for diagnosis, and methods include imaging or the Mantoux skin test. The report also details more complicated testing areas including drug resistance/susceptibility testing, DNA sequencing, solid-phase hybridization, microarrays, phage-based assays and many more.
Hospital Acquired Infections: Testing Markets
Published: August, 2012
Price: US$ 3.995,00
Kalorama Information’s report discusses the status of the field of HAI diagnostics as a setting-specific field of application. It reveals developments in this area, provides market size and epidemiological data, and profiles key players. It also gives segmented market data for molecular and conventional testing, covers the development of new testing systems and products and provides an analysis of growing drug resistance.
More information can be found in the report “Hospital Acquired Infections: Testing Markets” by Kalorama Information.
To order the report or ask for sample pages contact [email protected]